Efficacy and safety of ixazomib maintenance therapy for patients with multiple myeloma: a meta-analysis.
Huixian ChenYongjing WangChunchun ShaoChenxi SunChengyun ZhengPublished in: Hematology (Amsterdam, Netherlands) (2022)
= 0.62). Additionally, more RCTs are needed for better choice of treatment regimen.